| Cell line name | K-562R |
|---|---|
| Synonyms | K562R; K562-R |
| Accession | CVCL_5950 |
| Resource Identification Initiative | To cite this cell line use: K-562R (RRID:CVCL_5950) |
| Comments | Population: Caucasian. Selected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571). Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. |
| Sequence variations | |
| Disease | Blast phase chronic myelogenous leukemia, BCR-ABL1 positive (NCIt: C9110) Chronic myeloid leukemia (ORDO: Orphanet_521) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0004 (K-562) |
| Sex of cell | Female |
| Age at sampling | 53Y |
| Category | Cancer cell line |
| Cross-references | |
| Anatomy/cell type resources | BTO; BTO:0004462 |
| Chemistry resources | ChEMBL-Cells; CHEMBL4295438
ChEMBL-Targets; CHEMBL4296447 PubChem_Cell_line; CVCL_5950 |
| Encyclopedic resources | Wikidata; Q54899222 |
| Entry history | |
| Entry creation | 04-Apr-2012 |
| Last entry update | 29-Jun-2023 |
| Version number | 21 |